000 01564 a2200505 4500
005 20250514024157.0
264 0 _c20020610
008 200206s 0 0 eng d
022 _a0022-3417
024 7 _a10.1002/path.1045
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLynch, J
245 0 0 _aMitotic counts provide additional prognostic information in grade II mammary carcinoma.
_h[electronic resource]
260 _bThe Journal of pathology
_cMar 2002
300 _a275-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBreast Neoplasms
_xmortality
650 0 4 _aCarcinoma, Ductal, Breast
_xmortality
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aFlow Cytometry
650 0 4 _aHumans
650 0 4 _aKi-67 Antigen
_xanalysis
650 0 4 _aLogistic Models
650 0 4 _aLymphatic Metastasis
650 0 4 _aMiddle Aged
650 0 4 _aMitotic Index
650 0 4 _aPilot Projects
650 0 4 _aPrognosis
650 0 4 _aReceptors, Estrogen
_xanalysis
650 0 4 _aS Phase
650 0 4 _aSurvival Rate
700 1 _aPattekar, R
700 1 _aBarnes, D M
700 1 _aHanby, A M
700 1 _aCamplejohn, R S
700 1 _aRyder, K
700 1 _aGillett, C E
773 0 _tThe Journal of pathology
_gvol. 196
_gno. 3
_gp. 275-9
856 4 0 _uhttps://doi.org/10.1002/path.1045
_zAvailable from publisher's website
999 _c11765530
_d11765530